Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Torcetrapib cancellation leaves large hole in company's future revenues
Erdotin offers improved treatment but without increased costs
Increase in sales of OTC and prescription smoking-cessation products expected
But government stops short of advising on spending commitments
New chief executive wastes no time in making fundamental changes
Biggest ever salesforce reduction seen as a sign of the times
Acquisition provides important additions to Archimedes' specialist portfolio
Company responds by signing agreement to produce second generic
Novartis' Lucentis over first hurdle on road to EU approval
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches